Dupont DM - Search Results

1

Tumor-targeted polydiacetylene micelles for in vivo imaging and drug delivery.

Mackiewicz N, Gravel E, Garofalakis A, Ogier J, John J, Dupont DM, Gombert K, Tavitian B, Doris E, Ducongé F. Mackiewicz N, et al. Among authors: dupont dm. Small. 2011 Oct 4;7(19):2786-92. doi: 10.1002/smll.201100212. Epub 2011 Aug 12. Small. 2011. PMID: 21837631

2

In vivo validation of free-space fluorescence tomography using nuclear imaging.

Garofalakis A, Dubois A, Kuhnast B, Dupont DM, Janssens I, Mackiewicz N, Dollé F, Tavitian B, Ducongé F. Garofalakis A, et al. Among authors: dupont dm. Opt Lett. 2010 Sep 15;35(18):3024-6. doi: 10.1364/OL.35.003024. Opt Lett. 2010. PMID: 20847766

3

Serum-stable RNA aptamers to urokinase-type plasminogen activator blocking receptor binding.

Dupont DM, Madsen JB, Hartmann RK, Tavitian B, Ducongé F, Kjems J, Andreasen PA. Dupont DM, et al. RNA. 2010 Dec;16(12):2360-9. doi: 10.1261/rna.2338210. Epub 2010 Oct 20. RNA. 2010. PMID: 20962041 Free PMC article.

4

Biochemical properties of plasminogen activator inhibitor-1.

Dupont DM, Madsen JB, Kristensen T, Bodker JS, Blouse GE, Wind T, Andreasen PA. Dupont DM, et al. Front Biosci (Landmark Ed). 2009 Jan 1;14(4):1337-61. doi: 10.2741/3312. Front Biosci (Landmark Ed). 2009. PMID: 19273134 Free article. Review.

5

RNA aptamers as conformational probes and regulatory agents for plasminogen activator inhibitor-1.

Madsen JB, Dupont DM, Andersen TB, Nielsen AF, Sang L, Brix DM, Jensen JK, Broos T, Hendrickx ML, Christensen A, Kjems J, Andreasen PA. Madsen JB, et al. Among authors: dupont dm. Biochemistry. 2010 May 18;49(19):4103-15. doi: 10.1021/bi100066j. Biochemistry. 2010. PMID: 20387790

6

Dissecting the effect of RNA aptamer binding on the dynamics of plasminogen activator inhibitor 1 using hydrogen/deuterium exchange mass spectrometry.

Trelle MB, Dupont DM, Madsen JB, Andreasen PA, Jørgensen TJ. Trelle MB, et al. Among authors: dupont dm. ACS Chem Biol. 2014 Jan 17;9(1):174-82. doi: 10.1021/cb400619v. Epub 2013 Nov 14. ACS Chem Biol. 2014. PMID: 24138169

7

Tissue-type plasminogen activator-binding RNA aptamers inhibiting low-density lipoprotein receptor family-mediated internalisation.

Bjerregaard N, Bøtkjær KA, Helsen N, Andreasen PA, Dupont DM. Bjerregaard N, et al. Among authors: dupont dm. Thromb Haemost. 2015 Jul;114(1):139-49. doi: 10.1160/TH14-08-0686. Epub 2015 Apr 9. Thromb Haemost. 2015. PMID: 25855589

8

Expected and unexpected features of protein-binding RNA aptamers.

Bjerregaard N, Andreasen PA, Dupont DM. Bjerregaard N, et al. Among authors: dupont dm. Wiley Interdiscip Rev RNA. 2016 Nov;7(6):744-757. doi: 10.1002/wrna.1360. Epub 2016 May 12. Wiley Interdiscip Rev RNA. 2016. PMID: 27173731 Review.

9

A Conjugate of Two tPA-Binding RNA Aptamers Efficiently Inhibits Fibrinolysis.

Bjerregaard N, Dupont DM, Andreasen PA. Bjerregaard N, et al. Among authors: dupont dm. Nucleic Acid Ther. 2017 Apr;27(2):95-104. doi: 10.1089/nat.2016.0637. Epub 2017 Jan 4. Nucleic Acid Ther. 2017. PMID: 28051346

10

Mutational analysis of plasminogen activator inhibitor-1.

Wind T, Jensen JK, Dupont DM, Kulig P, Andreasen PA. Wind T, et al. Among authors: dupont dm. Eur J Biochem. 2003 Apr;270(8):1680-8. doi: 10.1046/j.1432-1033.2003.03524.x. Eur J Biochem. 2003. PMID: 12694181 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

31 results

Search Page